ofloxacin and bay y3118

ofloxacin has been researched along with bay y3118 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (75.00)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carlyn, CJ; Doyle, LJ; Knapp, CC; Ludwig, MD; Washington, JA1
Citron, DM; Goldstein, EJ; Nesbit, CA1
Borobio, MV; Conejo, M; Perea, EJ; Ramirez, E; Suarez, AI1
Molinari, G; Schito, GC1
Verbist, L; Verhaegen, J1
Barbara-Burnham, L; Bermudez, LE; Inderlied, CB; Kolonoski, P; Wu, M; Young, LS1
Castell, JV; Morlière, P; Ouédraogo, G; Santus, R1
Ahr, HJ; Blotz, A; Blümel, J; Dubertret, L; Michel, L; Moysan, A; Vohr, HW1

Other Studies

8 other study(ies) available for ofloxacin and bay y3118

ArticleYear
Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:7

    Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Quinolones; Spiro Compounds

1995
Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Bites, Human; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Wound Infection

1995
Comparative activities of eight quinolones against members of the Bacteroides fragilis group.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:6

    Topics: Anti-Infective Agents; Bacteroides fragilis; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones

1994
Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones.
    Drugs, 1995, Volume: 49 Suppl 2

    Topics: Aminoglycosides; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones

1995
Comparative in vitro activity of BAY Y 3118 against selected species.
    Drugs, 1995, Volume: 49 Suppl 2

    Topics: Anti-Infective Agents; Bacteria; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones

1995
Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:3

    Topics: Animals; Anti-Infective Agents; Cell Line; Drug Combinations; Ethambutol; Female; Fluoroquinolones; Humans; Levofloxacin; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolones; Rats

1996
Damage to mitochondria of cultured human skin fibroblasts photosensitized by fluoroquinolones.
    Journal of photochemistry and photobiology. B, Biology, 2000, Volume: 58, Issue:1

    Topics: Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Cytoplasm; Fibroblasts; Fluoroquinolones; Humans; Mitochondria; Norfloxacin; Ofloxacin; Photosensitizing Agents; Quinolones; Skin

2000
Analyses of cutaneous fluoroquinolones photoreactivity using the integrated model for the differentiation of skin reactions.
    Journal of photochemistry and photobiology. B, Biology, 2000, Volume: 58, Issue:1

    Topics: Administration, Oral; Administration, Topical; Animals; Anti-Infective Agents; Biomarkers; Cell Membrane; Enoxacin; Female; Fluoroquinolones; Irritants; Mice; Models, Biological; Ofloxacin; Phenotype; Photosensitizing Agents; Quinolones; Skin

2000